Everand Logo

Welcome to Everand!

  • STAT

    LISTEN: A lesson in startup jargon, pharma’s bare Alzheimer’s cupboard, and the cost of CAR-T

    How much is a shot at curing cancer worth? And what on Earth is an "oversubscribed Series A round"? Find out on this episode of our biotech podcast, "The Readout…
    by Damian Garde and Rebecca Robbins and Adam Feuerstein Aug 16, 2018 1 minute

    How much is a shot at curing cancer worth? Where are all the drugs for late-stage Alzheimer’s disease? And what on Earth is an “oversubscribed

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
    Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
    STAT1 min read
    STAT+: In Large Trial, Guardant Health’s Blood Test Detects Colon Cancer, But Less Reliably At Earliest Or Precancerous Stages
    If approved, Guardant Health’s liquid biopsy is likely to be a strong new addition to colorectal cancer screening tools, particularly for patients who currently choose not to get screened.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About An OptumRx Contract, 340B Dispute Resolution, And More
    Cardinal Health announced its pharmaceutical distribution contracts with UnitedHealth's OptumRx unit will not be renewed after they expire in June.

    Related Books & Audiobooks